Genomic and cDNA clones for the human nerve growth factor receptor have been used in conjunction with somatic cell hybrid analysis and in situ hybridization to localize the nerve growth factor receptor locus to human chromosome region 17ql2-q22. Additionally, part, if not all, of the nerve growth factor receptor locus is present on the translocated portion of 17q (17q21-qter) from a poorly differentiated acute leukemia in which the chromosome 17 breakpoint was indistinguishable cytogenetically from the 17 breakpoint observed in the t(15;17)(q22;q21) translocation associated with acute promyelocytic leukemia. Thus the nerve growth factor receptor locus may be closely distal to the acute promyelocytic leukemia-associated chromosome 17 breakpoint at 17q21.
The interaction between nerve growth factor and nerve growth factor receptor (NGFR) plays an essential role in the survival and maintenance of sympathetic and sensory neurons (1, 2). Nerve growth factor exerts pleiotropic effects on specific target cells during the development of the peripheral nervous system (3, 4) and these pleiotropic effects depend upon interaction of nerve growth factor with NGFR; NGFR has been detected on sensory and sympathetic neurons (5-7), human melanoma (8) and neuroblastoma (9) cells, and a rat adrenal tumor cell line (10, 11) ; in vivo it is expressed on cells derived from the neural crest (1, 2) .
Using monoclonal antibodies directed against NGFR (12) to identify mouse L cells expressing NGFR after gene transfer, genomic clones for NGFR have been isolated (37) . Complementary DNA (cDNA) clones were isolated from a A875 cDNA library by using genomic fragments as probes, and maps of the genomic locus and cDNA clones have been generated (37) .
Growth factor receptors are of particular interest due to their central position in signal transduction pathways; and NGFR is of special interest because of its limited distribution in developing tissue, its expression (or overexpression) in melanoma cells, and the range of pleiotropic effects of the nerve growth factor-receptor interaction.
It was ofparticular interest to determine the location ofthis receptor locus since the v-erbB oncogene appears to have been derived from a portion of the epidermal growth factor receptor gene (13) , and the oncogene carried by the McDonough strain of feline sarcoma virus has been reported to be related to the receptor for the macrophage growth factor CSF-1 (14) . Additionally, knowing the position of a gene in the human genome may provide clues to possible association of that gene with particular malignancies, other genetic lesions, or predispositions. By a combination of somatic cell hybrid analysis, in situ hybridization, and regional mapping in somatic cell hybrids containing translocated chromosomes, the NGFR locus has been shown to reside close to, in cytogenetic terms, and distal to the chromosome 17 breakpoint seen in the t(15;17)(q22;q21) associated with acute promyelocytic leukemia (APL) (15, 16) .
MATERIALS AND METHODS Molecular Probes. Genomic clones of the human NGFR locus have been isolated through gene transfer and subsequent rescue of the transforming DNA (37) . A partial restriction map of the genomic locus has been generated (37) and is depicted in Fig. 1 . The 5-kilobase (kb) BamHI fragment adjacent to the Alu sequence (Fig. 1, probe A ) was used to screen a XgtlO cDNA library made from cellular RNA isolated from A875, a human melanoma cell line expressing high levels of NGFR (8) , and NGFR cDNA clones were isolated (37) . Two cDNA clones pSPIF (Fig. 1, probe B) and p104 ( Fig. 1 , probe C) were used in this study. Probes A and B detect the same regions of the NGFR locus after HindIII (or EcoRI) digestion. Probe B was used for somatic cell hybrid analysis and for in situ hybridization studies and probes B and C were used to study the organization of the NGFR locus in DNA samples derived from leukemias. Other probes used in these studies were as follows: a human c-erbA (cHerbA) cDNA (18) ; a human homeobox homolog, C1 (19) , which maps to human chromosome 17 (K.H., J. Hurvitz, E. Boncinelli, C.M.C., unpublished data); and a human p53 cDNA Hp53, which contains the entire coding region for the p53 gene inserted into pBR322 (20) . In most cases, entire plasmids were used as probes; probe A was cleaved by BamHI from the XR9 genomic DNA, electrophoresed in agarose gel, purified from agarose (21) . All probes for Southern blots were labeled by nick-translation (22) by using one or several [a-32P]deoxynucleotide triphosphates.
Cells. Isolation, propagation, and characterization of parental cells and somatic cell hybrids used in this study have been described (18, (23) (24) (25) (26) (27) . All hybrids were characterized for expression of enzyme markers assigned to each of the human chromosomes (23 as described (23) . In addition, the presence of specific human chromosomes in many of the mouse-human hybrids have been confirmed by DNA hybridization by using probes for genes assigned to specific human chromosomes (18, (23) (24) (25) (26) (27) .
Tumor cells from'two patients with APL (designated C and S) with the characteristic t(15;17)(q22;q21) marker chromosomes (15, 16) and one patient with undifferentiated acute leukemia, designated L, with a t(17;21)(q21;q22) chromosome (18, 28) were also studied. The 275S hybrid cell line has been described and was isolated after fusion of the human leukemia L tumor cells with mouse L-M(TK-) cells. The only human chromosome retained in this hybrid' is a 21q+ (21pter-21q22::17q21-17qter) chromosome on a mouse cell background (18) .
Southern Blot Analysis. DNAs from human peripheral blood lymphocytes, human leukemia cells, mouse cell lines, and mouse-human hybrid cell lines were extracted by cell lysis, proteinase K digestion, phenol extraction, and ethanol precipitation. Cellular DNAs were digested with an excess of appropriate restriction enzymes, sized in 0.8% agarose gels and transferred to nitrocellulose or nylon filters as described by Southern (29) . Hybridization was carried out in 50% (vol/vol) formamide, 4x NaCl/Cit (lx NaCl/Cit is 0.15 M NaCl/0.015 M sodium citrate, pH 7.0), 0. Ci/mmol). The techniques used for in situ hybridization were essentially as described by Harper and Saunders (30) . Chromosome preparations were treated with pancreatic RNase A (Sigma) and then denatured in 70% (vol/vol) formamide in 2x NaCl/Cit (pH 7.0) at 70'C for 2 min. The chromosome preparations were then hybridized with 3H-labeled probe B NGFR DNA (specific activity 3 x 107 cpm/pug) at a concentration of 140 to 280 ng/ml in 50o (vol/vol} formamide/2x NaCl/Cit/20 mM NaH2PO4/10% (wt/vol) dextran sulfate (Pharmacia), pH 7.0, for 20 hr at 370C. A 300-fold excess of sonicated salmon sperm DNA was included as carrier. Slides were thoroughly rinsed in 50% (vol/vol) formamide, 2x NaCl/Cit at 390C, exposed to Kodak NTB2 nuclear track emulsion for 16 days at 40C, and developed with Kodak Dektol at 15'C. The chromosomes were then G banded essentially as described by Cannizzaro and Emanuel (31) with a mixture of 6 parts of borate buffer (50 mM Na2SO4/2.5 mM Na2B407, pH 9. (Fig. 1, probe A) DNA, from a panel of hybrid cells characterized for the presence of specific human chromosomes by isozyme analysis and, in some cases, by karyotypic analysis and by DNA-DNA hybridization that used DNA probes for genes assigned to specific chromosomes, was analyzed for the presence of the human NGFR gene as shown in Fig. 
2.
have been mapped to human chromosome 17 (18) (19) (20) (32) (33) (34) (35) , c-erbA (18), a human homeobox homolog (19) , and a human p53 cDNA (20) .
Localization of NGFR Gene to 17ql2-17q22 by in Situ Hybridization. The assignment of the NGFR locus to human chromosome 17 has been confirmed and refined by in situ hybridization of3H-labeled NGFR plasmid DNA (probe B) to metaphase chromosomes from peripheral blood lymphocytes of a normal male. After autoradiography, metaphase spreads were analyzed for grain localization. An example of one such spread is shown in Fig. 3 (Upper) . About 25% of all grains were located on the long arm of chromosome 17. Over 84% of the 17q grains were between 17q12 and 17q22, with most grains at 17q21. A histogram depicting the silver grain distribution along the human chromosomes is shown in Fig.  3 (Lower) . The long arm of chromosome 17 represents approximately 2.2% of the haploid genome, and our observation that more than 20% of the human NGFR probe hybridization was localized to the proximal half of this chromosome segment is highly significant (P < 0.001). Thus, cytological hybridization localizes the human NGFR gene to the region between 17q12 and 17q22, with most grains at 17q21.
Localization of the NGFR Locus to the Distal Side of the Leukemia-Associated Chromosome 17 Breakpoint. The localization of the human NGFR locus at 17ql2-17q22 places it close to the region containing one of the breakpoints in the t(15;17)(q22;q21) associated with APL. The c-erbA locus has been mapped to chromosome 17 proximal to the 17q21 APL breakpoint (18, 32) , but the gene locus which is at the chromosome 17 APL-associated breakpoint, which may be interrupted by translocation, has not yet been identified. Thus, it was of interest to determine where the NGFR locus resides relative to the APL 17q21 breakpoint. We have carried out Southern analysis of HindIII and EcoRI cleaved DNAs derived from leukemia patients and from a mouse-human hybrid (275S) retaining only a 21q+ (21pter-21q22::17q21-qter) chromosome (see Fig. 4 ) derived from a patient with undifferentiated acute leukemia (28) in a mouse L-M(TK-) background (18) . The breakpoint in chromosome 17 in this tumor was considered identical with that of the characteristic t(15;17) chromosome translocation breakpoint of APL (28) . The leukemia-derived and hybrid DNA containing filters were hybridized with an NGFR cDNA clone (Fig. 1, probe C) . Results are shown in Fig. Sa . The leukemia DNAs (Fig. Sa, lanes 3, 4, and 8-10 ) and hybrid 275S ( 4) is shown in Fig. 2 , lanes 9 and 7, respectively. Approximate molecular sizes of human NGFR and p53-specific fragments are shown beside the figure.
3.0-and 1.8-kbp bands falling between the 3.6 and 9.0-kbp band on the genomic locus; see Fig. 1 ) are detected only weakly by probe C (Fig. 5a ). On longer exposures ofthe x-ray film shown in Fig. 5a , the 3.6-, 3.0-, and 1.8-kbp HindIII fragments are seen in all three leukemia DNAs and in the 275S DNA. Note that the 275S DNA also exhibits mousespecific bands (compare lane 1 to lane 5 and lane 6 to lane 11). Thus, the NGFR probe C, the longest cDNA clone investigated, does not detect rearrangement in the NGFR locus with the restriction enzymes thus far tested.
As mentioned briefly above, we have routinely rehybridized NGFR blots with probes for other genes that have been mapped to chromosome 17. We find that the human p53 gene is absent from the 275S hybrid and is thus proximal to the 17q21 breakpoint of this tumor (see Fig. Sb, lane 5) . Another hybrid, which retains the long arm of chromosome 17 but has lost the short arm, retains the NGFR gene (Fig. 2, lane 7) but is negative for the human p53 gene (Fig. Sb, lane 4) , indicating that p53 maps to the short arm of chromosome 17 in agreement with a report (36) . In fact, in situ hybridization localizes the human p53 gene to 17p (38) . The leukemia DNAs thus far tested from two patients with APL (tumors C and S) and one patient with acute leukemia (tumor L) show a germline configuration for the NGFR region detected by probes B and C ( Fig. Sa and unpublished data) . Until probes derived from the 5' and 3' regions of the NGFR locus are tested, we cannot determine if the NGFR locus is directly altered by the t(15;17) translocation of APL; but our data from the t(17;21) translocation suggest that most, if not all, of the locus is distal to the breakpoint on chromosome 17.
DISCUSSION
The NGFR gene locus has been molecularly cloned by identification of transfectants that express NGFR (37) and characterized by restriction enzyme mapping of genomic and cDNA clones. This gene has now been localized in the human genome to chromosome region 17ql2-q22 by correlation between presence of the gene and presence of specific human chromosomes in a panel of mouse-human hybrids and by in situ hybridization of the labeled cDNA clone to metaphase chromosomes of a normal subject. The gene has been further localized as distal, and probably closely distal in cytogenetic distances, to the chromosome 17q21-q22 breakpoint observed in the t(15;17) chromosome associated with APL.
To determine which regions of chromosome 17 were present in each ofthe hybrid clones used for these studies, we have also determined the segregation pattern of three other genes that have been assigned to chromosome 17. We have confirmed that the human erbA locus is on 17 proximal to the APL chromosome 17 breakpoint; our data also indicate that a new member of the human homeobox gene cluster (19) is distal to the same breakpoint and that the human p53 locus is on the short arm of chromosome 17.
In preliminary investigations of two cases of APL with the typical t(15;17) translocation, we have also determined that the internal NGFR region detected by the available NGFR cloned probes is intact and that the same is true in the t(17;21) translocation observed in one case of poorly differentiated acute leukemia. It is possible that rearrangements indicating an involvement of the NGFR locus in the 17q21-q22 breakpoint will be detected by using cloned fragments from the 5' or 3' region ofthe NGFR locus. It will also be ofinterest to determine the genomic organization (germline, rearranged, amplified) of the NGFR locus in tumors of neural crest origin.
By virtue of its genomic location, the NGFR gene joins a linkage group whose other members, gene for thymidine kinase, galactokinase, homeobox genes, are linked in mouse (on chromosome 11) and man (17) . Thus the muine NGFR gene may be located on mouse chromosome 11. Due to its 
